Structural characterization of mucin O-glycosylation may provide important information to help prevent colorectal tumor recurrence

Frontiers in Oncology

Volumn 5, Issue OCT, 2015, Pages

  Mihalache, Adriana ^a,b   Delplanque, Jean François ^a   Ringot Destrez, Bélinda ^a   Wavelet, Cindy ^a   Gosset, Pierre ^b   Nunes, Bertrand ^b   Groux Degroote, Sophie ^a   Léonard, Renaud ^a   Robbe Masselot, Catherine ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

Author keywords

Colorectal cancer; Glycosylation; Human intestinal mucins; Prognosis; Recurrence

Indexed keywords

GLYCAN DERIVATIVE; MUCIN; OLIGOSACCHARIDE;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; MIDDLE AGED; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; STRUCTURE ANALYSIS; TUMOR RECURRENCE;

EID: 84947079762     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00217     Document Type: Article

References (55)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 49:1374-403. doi: 10.1016/j.ejca.2012.12.027
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell (1990) 61:759-67. doi:10.1016/0092-8674(90)90186-I
3. Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med (2009) 361:1179-87. doi:10.1056/NEJMcp0902176
4. Hakomori S-I. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res (1985) 45:2405-14.
5. Kannagi R, Yin J, Miyazaki K, Izawa M. Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori's concepts revisited. Biochim Biophys Acta (2008) 1780:525-31. doi:10.1016/j.bbagen.2007.10.007
6. Hakamori S-I. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipids metabolism. Cancer Res (1996) 56:5309-18.
7. Kim YJ, Varki A. Perspective on the significance of altered glycosylation in cancer. Glycoconj J (1997) 14:569-76. doi:10.1002/pmic.201100519
8. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, et al. Expression of Tn, Sialosyl-Tn, and T antigens in human colon cancer. Cancer Res (1989) 49:197-204.
9. Itzkowitz SH, Bloom EJ, Lau TS, Kim YS. Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut (1992) 33:518-23. doi:10.1136/gut.33.4.518
10. Itai S, Nishikata J, Yoneda T, Ohmori K, Yamabe H, Arii S, et al. Tissue distribution of 2-3 and 2-6 sialyl Lewis A antigens and significance of the ratio of two antigens for the differential diagnosis of malignant and benign disorders of the digestive tract. Cancer (1991) 67:1576-87. doi:10.1002/1097-0142(19910315)67:6<1576::AID-CNCR2820670620>3.0.CO;2-2
11. Yuan M, Itzkowitz SH, Palekar A, Shamsuddin AM, Phelps PC, Trump BF, et al. Distribution of blood group antigens A, B, H Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue. Cancer Res (1991) 45:4499-511.
12. Jass JR, Allison LJ, Edgar SG. Distribution of sialosyl-Tn and Tn antigens within normal and malignant colorectal epithelium. J Pathol (1995) 176:143-9. doi:10.1002/path.1711760207
13. Brockhausen I. Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells. Adv Exp Med Biol (2003) 535:163-88. doi:10.1007/978-1-4615-0065-0_11
14. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer (2009) 9:874-85. doi:10.1038/nrc2761
15. Vavasseur F, Dole K, Yang J, Matta KL, Myerscough N, Corfield A, et al. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem (1994) 222:415-24. doi:10.1111/j.1432-1033.1994.tb18880.x
16. Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep (2006) 7:599-604. doi:10.1038/sj.embor.7400705
17. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta (1999) 1473:67-95. doi:10.1016/S0304-4165(99)00170-1
18. Brockhausen I. Sulphotransferases acting on mucin-type oligosaccharides. Biochem Soc Trans (2003) 31:318-25. doi:10.1042/bst0310318
19. Robbe-Masselot C, Herrmann A, Maes E, Carlstedt I, Michalski JC, Capon C. Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon. J Proteome Res (2009) 8:702-11. doi:10.1021/pr800740j
20. Yang JM, Byrd JC, Siddiki BB, Chung YS, Okuno M, Sowa M, et al. Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology (1994) 4:873-84. doi:10.1093/glycob/4.6.873
21. Huang MC, Chen HY, Huang HC, Huang J, Liang JT, Shen TL, et al. C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. Oncogene (2006) 25:3267-76. doi:10.1038/sj.onc.1209350
22. Hung JS, Huang J, Lin YC, Huang MJ, Lee PH, Lai HS, et al. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2. Oncotarget (2014) 5:2096-106. doi:10.18632/oncotarget.1815
23. Komori T, Takemasa I, Higuchi H, Yamasaki M, Ikeda M, Yamamoto H, et al. Identification of differentially expressed genes involved in colorectal carcinogenesis using a cDNA microarray. J Exp Clin Cancer Res (2004) 23:521-7.
24. Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, Hiruma T, et al. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci U S A (2005) 102:4572-7. doi:10.1073/pnas.0407983102
25. González-Vallinas M, Vargas T, Moreno-Rubio J, Molina S, Herranz J, Cejas P, et al. Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer. Eur J Cancer (2015) 51:1-8. doi:10.1016/j.ejca.2014.10.021
26. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J (1997) 14:577-84. doi:10.1023/A:1018532409041
27. Robbe C, Capon C, Coddeville B, Michalski JC. Diagnostic ions for the rapid analysis by nano-electrospray ionization quadrupole time-of-flight mass spectrometry of O-glycans from human mucins. Rapid Commun Mass Spectrom (2004) 18:412-20. doi:10.1002/rcm.1352
28. Da Silva S, Robbe-Masselot C, Ait-Belgnaoui A, Mancuso A, Mercade-Loubière M, Salvador-Cartier C, et al. Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment. Am J Physiol Gastrointest Liver Physiol (2014) 307:G420-9. doi:10.1152/ajpgi.00290.2013
29. Joncquel Chevalier Curt M, Lecointe K, Mihalache A, Rossez Y, Gosset P, Léonard R, et al. Alteration or adaptation, the two roads for human gastric mucin glycosylation infected by Helicobacter pylori. Glycobiology (2015) 25:617-31. doi:10.1093/glycob/cwv004
30. Robbe C, Capon C, Coddeville B, Michalski JC. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J (2004) 384:307-16. doi:10.1042/BJ20040605
31. Larsson JM, Karlsson H, Crespo JG, Johansson ME, Eklund L, Sjövall H, et al. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis (2011) 17:2299-307. doi:10.1002/ibd.21625
32. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin (2011) 61:69-90. doi:10.3322/caac.20107
33. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev (2004) 23:77-99. doi:10.1023/A:1025815113599
34. Kudelka MR, Ju T, Heimburg-Molinaro J, Cummings RD. Simple sugars to complex disease. Mucin-type O-glycans in cancer. Adv Cancer Res (2015) 126:53-135. doi:10.1016/bs.acr.2014.11.002
35. Hanski C, Riede E, Gratchev A, Foss HD, Böhm C, Klussmann E, et al. MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. Lab Invest (1997) 77:685-95.
36. Myerscough N, Sylvester PA, Warren BF, Biddolph S, Durdey P, Thomas MG, et al. Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide. Glycoconj J (2001) 18:907-14. doi:10.1023/A:1022204626604
37. Losi L, Scarselli A, Benatti P, Ponz de Leon M, Roncucci L, Pedroni M, et al. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas. Pathol Res Pract (2004) 200:371-7. doi:10.1016/j.prp.2004.01.008
38. Arai T, Kasahara I, Sawabe M, Kanazawa N, Kuroiwa K, Honma N, et al. Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly: comparison with medullary type poorly differentiated adenocarcinoma. Pathol Int (2007) 57:205-12. doi:10.1111/j.1440-1827.2007.02082.x
39. Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer (2008) 122:1253-60. doi:10.1002/ijc.23225
40. Bartman AE, Sanderson SJ, Ewing SL, Niehans GA, Wiehr CL, Evans MK, et al. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer (1999) 80:210-8. doi:10.1002/(SICI)1097-0215(19990118)80:2<210::AID-IJC9>3.3.CO;2-L
41. Farhat MH, Barada KA, Tawil AN, Itani DM, Hatoum HA, Shamseddine AI. Effect of mucin production on survival in colorectal cancer: a case-control study. World J Gastroenterol (2008) 14:6981-5. doi:10.3748/wjg.14.6981
42. Holst S, Wuhrer M, Rombouts Y. Glycosylation characteristics of colorectal cancer. Adv Cancer Res (2015) 126:203-56. doi:10.1016/bs.acr.2014.11.004
43. Giuffre G, Vitarelli E, Tuccari G, Ponz de Leon M, Barresi G. Detection of Tn, sialosyl-Tn and T antigens in hereditary nonpolyposis colorectal cancer. Virchows Arch (1996) 429:345-52. doi:10.1007/BF00198438
44. Chik JH, Zhou J, Moh ESX, Christopherson R, Clarke SJ, Molloy MP, et al. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies. J Proteomics (2014) 108:146-62. doi:10.1016/j.jprot.2014.05.002
45. Schneider F, Kemmner W, Haensch W, Franke G, Gretschel S, Karsten U, et al. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res (2001) 61:4605-11.
46. Vavasseur F, Yang JM, Dole K, Paulsen H, Brockhausen I. Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R β3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines. Glycobiology (1995) 5:351-7. doi:10.1093/glycob/5.3.351
47. Ju T, Cummings RD. Protein glycosylation: chaperone mutation in Tn syndrome. Nature (2005) 437:1252. doi:10.1038/4371252a
48. Schietinger A, Philip M, Yoshida BA, Azadi P, Liu H, Meredith SC, et al. A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science (2006) 314:304-8. doi:10.1126/science.1129200
49. Kannagi R. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-the Warburg effect revisited. Glycoconj J (2004) 20:353-64. doi:10.1023/B:GLYC.0000033631.35357.41
50. Malagolini N, Santini D, Chiricolo M, Dall'Olio F. Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. Glycobiology (2007) 17:688-97. doi:10.1093/glycob/cwm040
51. Dohi T, Kawamura YI. Incomplete synthesis of the Sda/Cad blood group carbohydrate in gastrointestinal cancer. Biochim Biophys Acta (2008) 1780:467-71. doi:10.1016/j.bbagen.2007.08.019
52. Groux-Degroote S, Wavelet C, Krzewinski-Recchi MA, Portier L, Mortuaire M, Mihalache A, et al. B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract. Int J Biochem Cell Biol (2014) 53:442-9. doi:10.1016/j.biocel.2014.06.009
53. Robbe C, Capon C, Maes E, Rousset M, Zweibaum A, Zanetta JP, et al. Evidence of regio-specific glycosylation in human intestinal mucins: presence of an acidic gradient along the intestinal tract. J Biol Chem (2003) 278:46337-48. doi:10.1074/jbc.M302529200
54. Barrow H, Tam B, Duckworth CA, Rhodes JM, Yu LG. Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and core 3 glycans in human colon cancer cells. PLoS One (2013) 8:e59792. doi:10.1371/journal.pone.0059792
55. Ciucanu I, Kerek F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res (1984) 131:209-17. doi:10.1016/0008-6215(84)85242-8